Axogen Q1 2024 Adj EPS $(0.06) Beats $(0.07) Estimate, Sales $41.378M Miss $41.964M Estimate
Axogen Q1 2024 Adj EPS $(0.06) Beats $(0.07) Estimate, Sales $41.378M Miss $41.964M Estimate
Axogen 2024年第一季度調整後每股收益美元（0.06）超過預期（0.07），銷售額爲4137.8萬美元，低於419.64萬美元的預期
Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 40 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $41.378 million which missed the analyst consensus estimate of $41.964 million by 1.40 percent. This is a 12.86 percent increase over sales of $36.664 million the same period last year.
Axogen（納斯達克股票代碼：AXGN）公佈的季度虧損爲每股0.06美元，比分析師普遍預期的0.07美元（0.07美元）高出14.29％。這比去年同期每股虧損0.10美元（0.10）增長了40％。該公司公佈的季度銷售額爲4137.8萬美元，比分析師普遍預期的4196.4萬美元低1.40％。這比去年同期的366.64萬美元的銷售額增長了12.86％。